EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Battle of LPS Clearance in Host Defense vs. Inflammatory Signaling

Pankaj Kumar iD, Evan A Schroder iD, Murugesan V S Rajaram, Edward N Harris iD, Latha P Ganesan iD

Cells · 21.09.2024 · 13 (18) · 1590

DOI: 10.3390/cells13181590 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 21.09.2024. Verfasst von Pankaj Kumar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH 43210, USA. Hauptthemen laut MEDLINE: Lipopolysaccharides, Signal Transduction, Inflammation. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 198 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIAID.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipopolysaccharide (LPS) in blood circulation causes endotoxemia and is linked to various disease conditions. Current treatments focus on preventing LPS from interacting with its receptor Toll-like receptor 4 (TLR4) and reducing inflammation. However, our body has a natural defense mechanism: reticuloendothelial cells in the liver rapidly degrade and inactivate much of the circulating LPS within minutes. But this LPS clearance mechanism is not perfect. Excessive LPS that escape this clearance mechanism cause systemic inflammatory damage through TLR4. Despite its importance, the role of reticuloendothelial cells in LPS elimination is not well-studied, especially regarding the specific cells, receptors, and mechanisms involved. This gap hampers the development of effective therapies for endotoxemia and related diseases. This review consolidates the current understanding of LPS clearance, narrates known and explores potential mechanisms, and discusses the relationship between LPS clearance and LPS signaling. It also aims to highlight key insights that can guide the development of strategies to reduce circulating LPS by way of bolstering host defense mechanisms. Ultimately, we seek to provide a foundation for future research that could lead to innovative approaches for enhancing the body’s natural ability to clear LPS and thereby lower the risk of endotoxin-related inflammatory diseases, including sepsis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipopolysaccharidesSignal TransductionInflammationHumansAnimalsEndotoxemiaToll-Like Receptor 4

Stichwörter der Autor:innen

Kupffer cellsLPSLSECsclearanceendotoxemiaendotoxin associated diseasesliverscavenger receptorssepsissignaling

Substanzen

LipopolysaccharidesToll-Like Receptor 4

Autor:innen und Institutionen

  • Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
  • Department of Biochemistry, University of Nebraska, Lincoln, NE 68588, USA.
  • Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.

ORCID-Profile: Pankaj Kumar, Evan A Schroder, Edward N Harris, Latha P Ganesan

Förderung

  • NIAID NIH HHS
  • NIAID

Zitieren

APA

Kumar, P., Schroder, E. A., Rajaram, M. V. S., Harris, E. N., & Ganesan, L. P. (2024). The Battle of LPS Clearance in Host Defense vs. Inflammatory Signaling. Cells, 13(18), 1590. https://doi.org/10.3390/cells13181590

Vancouver

Kumar P, Schroder EA, Rajaram MVS, Harris EN, Ganesan LP. The Battle of LPS Clearance in Host Defense vs. Inflammatory Signaling. Cells. 2024;13(18):1590. doi:10.3390/cells13181590

BibTeX
@article{Kumar2024,
  author = {Kumar, Pankaj and Schroder, Evan A and Rajaram, Murugesan V S and Harris, Edward N and Ganesan, Latha P},
  title = {The Battle of LPS Clearance in Host Defense vs. Inflammatory Signaling},
  journal = {Cells},
  year = {2024},
  volume = {13},
  number = {18},
  pages = {1590},
  doi = {10.3390/cells13181590}
}
Kostenlos starten →